Pricing Log in Create free account

Ocugen, Inc. (OCGN) vs Turn Therapeutics Inc. (TTRX)

Ocugen, Inc. and Turn Therapeutics Inc. are both Biotechnology companies. Ocugen, Inc. and Turn Therapeutics Inc. are of similar size ($276.9M and $273.0M). Turn Therapeutics Inc. has the higher net margin (0.00% vs −1,367.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Turn Therapeutics Inc. leads on 6 and Ocugen, Inc. on 5.

Valuation

Metric OCGN TTRX Biotechnology median
P/E n/m n/m 10.60
P/S 66.01 n/m 9.40
P/B n/m 403.30 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 48.75 n/m 9.02
Earnings yield (21.57%) (3.12%) (32.88%)
Free cash flow yield (20.26%) (1.61%) (23.13%)

Profitability

Metric OCGN TTRX Biotechnology median
Gross margin 100.00% — 68.51%
Operating margin (1,444.47%) 0.00% 0.00%
Net margin (1,367.61%) 0.00% 0.00%
Free cash flow margin (1,337.16%) 0.00% 0.00%
Return on equity 923.92% (3,315.33%) (51.96%)
Return on assets (78.91%) (99.59%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric OCGN TTRX Biotechnology median
Revenue growth (TTM) (11.01%) — 6.76%
EPS growth (last fiscal year) (15.00%) (80.72%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric OCGN TTRX Biotechnology median
Debt to equity (0.10) 8.83 0.00
Current ratio 0.77 1.19 4.97
Net debt to EBITDA (0.17) 0.96 1.01

Dividend

Metric OCGN TTRX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric OCGN TTRX Biotechnology median
Market cap 276.88m 272.96m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack